ArticleNeurology and therapy2023

Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing-Remitting Multiple Sclerosis: STRIVE Data Analysis.

Jai Perumal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.